Delivery Order SPE2DB22D1106-SPE2DB25FFDV3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packaging). The contract is valued at $9,434.27 under a firm fixed-price arrangement with an ultimate completion date of August 15, 2025. This delivery order was awarded competitively with no set-aside designation and represents performance at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $2,756.79 and an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The performance location is the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a contract ceiling value of $3,305.63. This is a firm fixed-price delivery order executed without a set-aside designation, indicating competitive award through open procurement. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $6,612.84. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger federal contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,174.62 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract represents a small-value pharmaceutical delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $4,048.75. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $1,011.63. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $5,968.23. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This delivery order, awarded July 22, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Carvedilol ER 20 mg capsules in quantities of 30 under a firm fixed-price contract valued at $9,214.06. The contract is scheduled for completion by July 23, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award utilizes no set-aside designation and represents a competitive procurement from the vendor's established...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDV3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) under a firm fixed-price contract valued at $1,279.74. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the vendor's broader federal pharmaceutical supply portfolio serving military and veteran healthcare systems. This award is a child contract issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The vendor's federal contract activity demonstrates consistent capability to fulfill competitive federal procurement requirements across diverse therapeutic domains through firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/18/25 |